PNC Financial Services Group’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

PNC Financial Services Group’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40.8K	Hold	500	–	–	﹤0.01%	3336
2025 Q4	$39.9K	Hold	500	–	–	﹤0.01%	3338
2025 Q3	$29.8K	Buy	+500	New	+$26.9K	﹤0.01%	3471
2025 Q2	–	Sell	-1,000	Closed	-$48.2K	–	4921
2025 Q1	$48.2K	Buy	+1,000	New	+$53.6K	﹤0.01%	3120
2019 Q4	–	Sell	-1,145	Closed	-$49K	–	3984
2019 Q3	$49K	Hold	1,145	–	–	﹤0.01%	2914
2019 Q2	$59K	Buy	+1,145	New	+$57K	﹤0.01%	2849
2019 Q1	–	Sell	-1,000	Closed	-$42K	–	4027
2018 Q4	$42K	Hold	1,000	–	–	﹤0.01%	2965
2018 Q3	$70K	Hold	1,000	–	–	﹤0.01%	2801
2018 Q2	$57K	Hold	1,000	–	–	﹤0.01%	2892
2018 Q1	$55K	Hold	1,000	–	–	﹤0.01%	2909
2017 Q4	$56K	Buy	+1,000	New	+$56.4K	﹤0.01%	2888

Other funds holding BIB

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

KFS

Kaizen Financial Strategies Campbell, California $308M AUM 41.73% 1-Year Est. Return

PWM

Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return

CAG

Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ATPW

Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

PNC Financial Services Group's BIB Position: Q1 2026 in Review

PNC Financial Services Group held its ProShares Ultra NASDAQ Biotechnology (BIB) position steady in Q1 2026 at 500 shares worth $40.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3336.

PNC Financial Services Group first reported a position in BIB in Q4 2017 and has held it in 11 quarters since. The position peaked at $70K in Q3 2018. 23 funds tracked by Wall St. Rank hold BIB as of Q1 2026.

PNC Financial Services Group held 500 shares of ProShares Ultra NASDAQ Biotechnology worth $40.8K as of Q1 2026.
PNC Financial Services Group left its ProShares Ultra NASDAQ Biotechnology share count unchanged in Q1 2026.
ProShares Ultra NASDAQ Biotechnology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3336 holding.
PNC Financial Services Group first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2017 and has held it in 11 quarters since.
PNC Financial Services Group's ProShares Ultra NASDAQ Biotechnology position peaked at $70K in Q3 2018.
23 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.